Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

75
End-of-day quote. End-of-day quote CHI-X EUROPE LIMITED. - 11/30
0.0000 EUR   0.00%
2d ago PCAS : ENERSENS Homeskin project
2d ago PCAS : leads the European Union Horizon 2020 Homeskin
12/04 PCAS : includes a new Scientific Board in its governance
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

PCAS : quarterly financial reporting Sep 30, 2011

10/07/2011 | 11:40am US/Eastern

Quarterly financial reporting
As of 30 September 2011

 

 

Business update

 

(in thousands of euros)20112010% change
 First Quarter44,05341,4346,3%
 including Pharmaceutical Synthesis27,14726,6032,0%
 including Specialty Chemicals16,90614,83114,0%
 Second Quarter41,78942,698-2,1%
 including Pharmaceutical Synthesis26,45728,100-5,8%
 including Specialty Chemicals15,33214,5985,0%
 Third Quarter33,48133,658-0,5%
 including Pharmaceutical Synthesis19,53018,3946,2%
 including Specialty Chemicals13,95115,264-8,6%
 Total as of 30 September119,323117,7901,3%
 including Pharmaceutical Synthesis73,13473,0970,1%
 including Specialty Chemicals46,18944,6933,3%

 

 

 

The PCAS Group's consolidated revenues at 30 September 2011came in 1.3% higher than the same period the previous year.

 

Pharmaceutical Synthesis
Over the first five months of the year, business was affected by the planned reduction in the contribution by the new contract between PCAS and Sanofi, effective since 31 May 2010. Excluding this contract, the Exclusive and Non-Exclusive Pharma business is up 10.5% at 30 September 2011.
Fine Specialty Chemicals
With growth of 3.3% at 30 September 2011, the Fine Specialty Chemicals business contracted by 8.6% during the third quarter of 2011 in relation to 2010, reflecting the economic slowdown seen since the summer.

 

Key operations and events for the quarter

 

No important events likely to have a significant impact on the company's business or situation occurred during the third quarter of 2011.

 

Outlook for the current year

 

The high level of sales expected for the fourth quarter should lead to earnings growth in 2011.

 

 

Next date :  2011 earnings, February 22nd, 2012

 

 

About PCAS
PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.

 

Longjumeau, October 7th, 2011

 

PCAS_T3_2011_EN:
http://hugin.info/143512/R/1553112/478624.pdf



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE

HUG#1553112
React to this article
Latest news on PCAS
2d ago PCAS : ENERSENS Homeskin project
2d ago PCAS : leads the European Union Horizon 2020 Homeskin
12/04 PCAS : includes a new Scientific Board in its governance
12/03 PCAS : Protéus : At the heart of the Vadébio project
12/03 PCAS : joins the new EnterNext© PEA-PME 150 index
12/02 PCAS : through its subsidiary Proteus, is contributing to the conversion of wood..
11/24 PCAS : CONTRACT AWARD - Y-- CARD-1 PCAS/Repl Electrical Switchgears
11/12 PCAS : joins the new EnterNext© PEA-PME 150 index
11/11 RAYTHEON : starts persistent close air support programme flight tests
11/10 RAYTHEON : Flight Tests Persistent Close Air Support Program
Advertisement
Chart
Duration : Period :
PCAS Technical Analysis Chart | PCA | FR0000053514 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF